Aadi Bioscience, Inc. (AADI )

Currency in USD Disclaimer
$3.39 +$1.07 (46.12%)
Closed 12/20/2024
$2.07
$3.6
$1.21
$3.6

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol AADI
  • Company Aadi Bioscience, Inc.
  • Price $3.39
  • Changes Percentage 46.12
  • Change 1.07
  • Day Low $2.07
  • Day High $3.6
  • Year High $3.6
  • Year Low $1.21
  • Market Cap $83,554,686
  • Price Avg 50 EMA (D) $2.19
  • Price Avg 200 EMA (D) $1.89
  • Exchange NASDAQ
  • Volume 8,803,871
  • Average Volume 107,049
  • Open $2.52
  • Previous Close $2.32
  • EPS -2.28
  • PE -1.49
  • Earnings Announcement 2025-03-11 12:30:00
  • Shares Outstanding $24,647,400

Company brief: AADI BIOSCIENCE, INC. (AADI )

Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.

AADI Corporation News

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?

December 20, 2024 at 1:43 pm ET

benzinga.com -- On Thursday, Aadi Bioscience, Inc.  AADI entered into an exclusive license agreement for the development and global commercialization of a three-asset portfolio of preclinical antibody-drug conjugate...

Income Statement